In the context of neurodegenerative research, "antitauons" refer to or therapeutic agents designed to neutralize tauons —the prion-like, pathological forms of the tau protein that spread from neuron to neuron. Overview of Tauons and Antitauons
Current research focuses on both to combat these tauon species: Example Agents / Trials Passive Immunotherapy antitauon
Promoting the removal of pathological tau via microglia or through intracellular degradation pathways like the proteasome. Key Therapeutic Strategies In the context of neurodegenerative research
Small Phase I studies have shown ASOs are safe and can reduce aggregated tau. Current Challenges and Clinical Status antitauon